Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 65, Issue 6
Volume 65, Issue 6
15 September 2017
ISSN 1058-4838
EISSN 1537-6591

Volume 65, Issue 6, 15 September 2017

NEWS

Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages i–ii, https://doi.org/10.1093/cid/cix650

IN THE LITERATURE

Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages iii–iv, https://doi.org/10.1093/cid/cix688

ARTICLES AND COMMENTARIES

Umme-Aiman Halai and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 877–883, https://doi.org/10.1093/cid/cix472

Maternal Zika symptom severity or ZIKA-RNA load at time of infection did not impact birth outcomes in our cohort analysis. Presence of prior maternal dengue antibodies had no effect on Zika infection severity, RNA load, or birth outcomes.

Linda M Niccolai and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 884–889, https://doi.org/10.1093/cid/cix455

Significant declines in high-grade cervical lesions have occurred among young women since 2008. The age and cohort patterns in declines suggest they are more likely driven by human papillomavirus vaccination than by changes in screening or risk behaviors.

Suzanne M Garland and Dorothy A Machalek
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 890–892, https://doi.org/10.1093/cid/cix459
Emily A Burger and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 893–899, https://doi.org/10.1093/cid/cix475

Although new HPV infections and associated precancers can occur throughout a woman’s lifetime, only a small proportion are acquired in mid-adult women and are vaccine-preventable. Our model-based explorations provide insight into causal HPV infections and highlight the potential limitations of using surrogate endpoints for vaccine efficacy studies of mid-adult women to guide policy decisions for implementation.

Omowunmi Aibana and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 900–909, https://doi.org/10.1093/cid/cix476

Vitamin A deficiency was associated with a 10-fold increase in risk of developing TB disease after household exposure. Vitamin A supplementation among high risk individuals might represent an effective means of preventing progression from TB infection to TB disease.

Emily S Spivak and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 910–917, https://doi.org/10.1093/cid/cix474

The majority of bacteriuria among inpatient Veterans represents asymptomatic bacteriuria with a large proportion of patients unnecessarily treated with prolonged durations of therapy for both asymptomatic bacteriuria and symptomatic urinary tract infections.

Alan R Katz and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 918–923, https://doi.org/10.1093/cid/cix485

We report on a cluster of Neisseria gonorrhoeae isolates identified on Oahu, Hawaii, that demonstrate high-level azithromycin resistance and decreased ceftriaxone susceptibility. Continued mutation and widespread emergence of such strains may severely complicate gonorrhea treatment.

Edward W Hook
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 924–926, https://doi.org/10.1093/cid/cix492
Sheng-Wei Pan and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 927–934, https://doi.org/10.1093/cid/cix479

About 60% of patients with Mycobacterium avium complex lung disease had microbiological persistence >1 year, indicating a 3-fold increased risk for radiographic progression. Low body mass index, nodular-bronchiectatic radiographic pattern, and high acid-fast bacilli smear grade significantly predicted microbiological persistence.

Annelene Kossow and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 935–942, https://doi.org/10.1093/cid/cix465

Through major reconstruction of the water and sanitary system, we were able to significantly reduce the burden of Pseudomonas aeruginosa infections and colonizations in allogeneic hematopoietic stem cell transplant recipients as a high-risk patient group.

Emily L Ho and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 943–948, https://doi.org/10.1093/cid/cix473

Compared to those without cognitive impairment, HIV-infected individuals with syphilis who were cognitively impaired had higher CSF concentrations of mediators associated with HIV-related cognitive impairment.

Katja Wyss and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 949–958, https://doi.org/10.1093/cid/cix437

In this nationwide observational study of 937 adults diagnosed with Plasmodium falciparum malaria in Sweden, Charlson comorbidity score ≥1 as well as diabetes and obesity were significantly associated with severe malaria in both nonimmune travelers and immigrants from endemic countries.

Adam Trickey and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 959–966, https://doi.org/10.1093/cid/cix466

Associations of CD4:CD8 ratio or CD8 count with all-cause and cause-specific mortality were too small for them to be useful as independent prognostic markers in addition to CD4 count in virally suppressed patients on antiretroviral therapy with high CD4 count.

Jonathan M Mansbach and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 967–975, https://doi.org/10.1093/cid/cix483

Among infants hospitalized with bronchiolitis, low serum LL-37 levels were independently associated with intensive care use and longer length-of-stay. Low levels of serum LL-37 were also independently associated with respiratory syncytial virus. By contrast, high LL-37 levels were associated with rhinovirus.

Pilar Rojas and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 976–981, https://doi.org/10.1093/cid/cix454

This is the first research to evaluate Pneumocystis jirovecii colonization in preterm births, showing it is a frequent occurrence that could be a risk factor until now unknown to develop respiratory distress syndrome among preterm infants.

Jennifer Jao and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 982–989, https://doi.org/10.1093/cid/cix488

Overall lack of association between maternal perinatal human immunodeficiency virus (HIV) infection and preterm delivery or infant birth weight (BW) is reassuring. The higher rates of low BW observed in older women with perinatally acquired HIV may warrant further investigations.

Max R Schroeder and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 990–998, https://doi.org/10.1093/cid/cix446

Macrolide-resistant Streptococcus pneumoniae containing both mef(E)/mel and erm(B) rapidly expanded (2005–2009) but decreased following pneumococcal conjugate vaccine 13 introduction. Macrolide-resistant serotypes not represented in vaccines increased modestly. Selective pressures of macrolide use and vaccine introductions were associated with these changes.

Mohamed Hashem and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 999–1005, https://doi.org/10.1093/cid/cix445

Spontaneous resolution of chronic hepatitis C virus (HCV) infection is a rare event. We describe spontaneous resolution in 26.9% of a cohort of HCV-infected women by 12-months post-partum. Understanding the underlying immunological changes in similar cohorts could inform immune therapies and vaccine development.

Adeel Ajwad Butt and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1006–1011, https://doi.org/10.1093/cid/cix364

In a study of 1473 persons on paritaprevir/ritonavir, ombitasvir, dasabuvir (PrOD), 5497 on ledipasvir/sofosbuvir (LDV/SOF), and 6970 propensity score–matched untreated persons, treatment with LDV/SOF or PrOD was associated with a 57% reduction in mortality. Benefit was apparent within the first 18 months of treatment.

Juan Macías and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1012–1019, https://doi.org/10.1093/cid/cix467

Antiretroviral drugs less likely to induce steatosis progression are needed. In this clinical trial, we found that switching efavirenz by raltegravir was associated with decreases in steatosis among HIV-infected patients with nonalcoholic fatty liver disease.

VIEWPOINTS

Lindsay Kim and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1020–1025, https://doi.org/10.1093/cid/cix432

With the development of respiratory syncytial virus (RSV) vaccines, monoclonal antibodies, and antivirals, unanswered questions regarding RSV epidemiology need to be identified and addressed prior to introduction of vaccines and RSV therapeutics to guide the measurement of impact and future recommendations.

REVIEW ARTICLE

Andrea H L Bruning and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1026–1032, https://doi.org/10.1093/cid/cix461

This meta-analysis evaluates the diagnostic accuracy of rapid tests for the detection of respiratory viruses. Sensitivity of tests varied considerably, but specificity was high. Although newly developed tests seem more sensitive, high quality evaluations of these tests are lacking.

BRIEF REPORTS

Mazyar Mahmoudi and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1033–1036, https://doi.org/10.1093/cid/cix443
Natalie Nesmith and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1037–1039, https://doi.org/10.1093/cid/cix471
Marwan M Azar and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1040–1042, https://doi.org/10.1093/cid/cix460
Catherine E Cavanaugh and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1043–1046, https://doi.org/10.1093/cid/cix435

PHOTO QUIZ

Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Page 1047, https://doi.org/10.1093/cid/cix414

ANSWER TO THE PHOTO QUIZ

S De Meulder and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1048–1049, https://doi.org/10.1093/cid/cix415

CORRESPONDENCE

Mark Jones and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Page 1050, https://doi.org/10.1093/cid/cix425
Sudhir Venkatesan and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Page 1051, https://doi.org/10.1093/cid/cix427
Céline Boschi and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1051–1053, https://doi.org/10.1093/cid/cix457
David Zucman and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1053–1054, https://doi.org/10.1093/cid/cix458
Didier Raoult
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1054–1055, https://doi.org/10.1093/cid/cix469
Stephan P Keijmel and others
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Pages 1055–1056, https://doi.org/10.1093/cid/cix470

ERRATA

Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Page 1057, https://doi.org/10.1093/cid/cix453
Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Page 1057, https://doi.org/10.1093/cid/cix522

COVER

Clinical Infectious Diseases, Volume 65, Issue 6, 15 September 2017, Page NP, https://doi.org/10.1093/cid/cix671
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close